When are pregnancy tests required for women of childbearing potential taking vismodegib (Erivedge)?

Women of childbearing potential taking Erivedge (vismodegib) require a negative, medically supervised pregnancy test conducted by a healthcare provider within 7 days before starting and monthly during treatment, even with amenorrhoea, using tests with a minimum sensitivity of 25 mIU/mL as locally available.